Evidence map›Paper›PMID 38034055›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2023

Relationship between human herpesvirus 6 infection and inflammatory bowel disease using novel biomarker.

Satohiro Matsumoto, Yuzo Otaki, Yukio Yoshida, Nobuyuki Kobayashi, Naomi Oka, Hiroyuki Yanagisawa, Kazuhiro Kondo

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Satohiro MatsumotoDepartment of Gastroenterology Jichi Medical University Saitama Medical Center Saitama Saitama Japan.ORCID https://orcid.org/0000-0001-7802-3980
Yuzo OtakiDepartment of Gastroenterology Jichi Medical University Saitama Medical Center Saitama Saitama Japan.
Yukio YoshidaDepartment of Gastroenterology Jichi Medical University Saitama Medical Center Saitama Saitama Japan.
Nobuyuki KobayashiDepartment of Virology The Jikei University School of Medicine Minato City Tokyo Japan.ORCID https://orcid.org/0000-0001-8627-515X
Naomi OkaDepartment of Virology The Jikei University School of Medicine Minato City Tokyo Japan.
Hiroyuki YanagisawaDepartment of Public Health & Environmental Medicine The Jikei University School of Medicine Minato City Tokyo Japan.
Kazuhiro KondoDepartment of Virology The Jikei University School of Medicine Minato City Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Inflammatory bowel disease (IBD) is closely related to stress and fatigue. Human herpesvirus 6B (HHV-6B) is reactivated by stress and fatigue and is associated with IBD. This study aimed to clarify the relationship between IBD and HHV-6B. Methods: Antibody titers to SITH-1, a protein specific to HHV-6B latent infection, were measured in 163 patients with IBD (107 with ulcerative colitis [UC] and 56 with Crohn's disease [CD]); clinical and endoscopic scores and depression scores of UC and CD were analyzed to examine the relationship between SITH-1 and IBD. The SITH-1 cut-off value was set as 1.96, according to known reports. Results: In patients with UC, C-reactive protein (CRP) level was significantly higher (1.5 Conclusion: Patients with UC with high titers of SITH-1 have high disease activity and frequent disease exacerbation. SITH-1 can be associated with UC disease activity.

Indexed as

Crohn's diseasehuman herpesvirus 6SITH‐1ulcerative colitis

Identifiers

PMID38034055
PMCPMC10684980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.